1. Home
  2. CMTL vs ATNM Comparison

CMTL vs ATNM Comparison

Compare CMTL & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$5.28

Market Cap

162.1M

Sector

Technology

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.13

Market Cap

45.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
ATNM
Founded
1967
2000
Country
United States
United States
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.1M
45.2M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
CMTL
ATNM
Price
$5.28
$1.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$4.00
AVG Volume (30 Days)
296.0K
113.7K
Earning Date
03-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.60
EPS
N/A
N/A
Revenue
$499,528,000.00
$81,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$1.02
52 Week High
$6.21
$1.95

Technical Indicators

Market Signals
Indicator
CMTL
ATNM
Relative Strength Index (RSI) 46.21 46.79
Support Level $4.86 $1.02
Resistance Level $6.15 $1.71
Average True Range (ATR) 0.35 0.08
MACD -0.10 0.02
Stochastic Oscillator 36.36 63.00

Price Performance

Historical Comparison
CMTL
ATNM

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: